Seems though that given SAMR is the most important thing for a2, it might be worth that alone to take control as means not relying on what is clearly an incompetent entity to take care of such an important item.. Also whose to say that this situation Synlait is in is actually what is holding up the approval, couldn't rule that out. That big of a debt and other failings likely a big distraction.
If they have a SAMR application underway through MVM then probably don't need but how long is that away and is that even guranteed.
A2M Price at posting:
$5.98 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)